269 related articles for article (PubMed ID: 32280557)
1. Regulation of bile acid receptor activity
Wan YY; Sheng L
Liver Res; 2018 Dec; 2(4):180-185. PubMed ID: 32280557
[TBL] [Abstract][Full Text] [Related]
2. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases.
Guan B; Tong J; Hao H; Yang Z; Chen K; Xu H; Wang A
Acta Pharm Sin B; 2022 May; 12(5):2129-2149. PubMed ID: 35646540
[TBL] [Abstract][Full Text] [Related]
3. Bile Acid Receptors and Gastrointestinal Functions.
Ticho AL; Malhotra P; Dudeja PK; Gill RK; Alrefai WA
Liver Res; 2019 Mar; 3(1):31-39. PubMed ID: 32368358
[TBL] [Abstract][Full Text] [Related]
4. Bile Acids in Hepatic Encephalopathy.
DeMorrow S
J Clin Exp Hepatol; 2019; 9(1):117-124. PubMed ID: 30774268
[TBL] [Abstract][Full Text] [Related]
5. Bile acids as global regulators of hepatic nutrient metabolism.
Hylemon PB; Takabe K; Dozmorov M; Nagahashi M; Zhou H
Liver Res; 2017 Jun; 1(1):10-16. PubMed ID: 29123941
[TBL] [Abstract][Full Text] [Related]
6. Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism.
Kwong E; Li Y; Hylemon PB; Zhou H
Acta Pharm Sin B; 2015 Mar; 5(2):151-7. PubMed ID: 26579441
[TBL] [Abstract][Full Text] [Related]
7. Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy.
Nenkov M; Shi Y; Ma Y; Gaßler N; Chen Y
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203175
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation.
Thibaut MM; Bindels LB
Trends Mol Med; 2022 Mar; 28(3):223-236. PubMed ID: 35074252
[TBL] [Abstract][Full Text] [Related]
9. Counter-regulatory role of bile acid activated receptors in immunity and inflammation.
Fiorucci S; Cipriani S; Mencarelli A; Renga B; Distrutti E; Baldelli F
Curr Mol Med; 2010 Aug; 10(6):579-95. PubMed ID: 20642438
[TBL] [Abstract][Full Text] [Related]
10. Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.
Chiang JY; Pathak P; Liu H; Donepudi A; Ferrell J; Boehme S
Dig Dis; 2017; 35(3):241-245. PubMed ID: 28249273
[TBL] [Abstract][Full Text] [Related]
11. Bile acid nuclear receptor FXR and digestive system diseases.
Ding L; Yang L; Wang Z; Huang W
Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
[TBL] [Abstract][Full Text] [Related]
12. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
13. Bile Acid-Activated Receptors: GPBAR1 (TGR5) and Other G Protein-Coupled Receptors.
Keitel V; Stindt J; Häussinger D
Handb Exp Pharmacol; 2019; 256():19-49. PubMed ID: 31302759
[TBL] [Abstract][Full Text] [Related]
14. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
15. The contributions of bacteria metabolites to the development of hepatic encephalopathy.
Gilbert MC; Setayesh T; Wan YY
Liver Res; 2023 Dec; 7(4):296-303. PubMed ID: 38221945
[TBL] [Abstract][Full Text] [Related]
16. Bile acid-activated receptors in the treatment of dyslipidemia and related disorders.
Fiorucci S; Cipriani S; Baldelli F; Mencarelli A
Prog Lipid Res; 2010 Apr; 49(2):171-85. PubMed ID: 19932133
[TBL] [Abstract][Full Text] [Related]
17. Bile acid treatment and FXR agonism lower postprandial lipemia in mice.
Farr S; Stankovic B; Hoffman S; Masoudpoor H; Baker C; Taher J; Dean AE; Anakk S; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G682-G693. PubMed ID: 32003602
[TBL] [Abstract][Full Text] [Related]
18. Proanthocyanidin B2 derived metabolites may be ligands for bile acid receptors S1PR2, PXR and CAR: an
Hoang SH; Tveter KM; Mezhibovsky E; Roopchand DE
J Biomol Struct Dyn; 2024 May; 42(8):4249-4262. PubMed ID: 37340688
[TBL] [Abstract][Full Text] [Related]
19. Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology.
Brønden A; Knop FK
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31630179
[TBL] [Abstract][Full Text] [Related]
20. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
Donepudi AC; Boehme S; Li F; Chiang JY
Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
